BioLineRx (BLRX) Profit After Tax (2023 - 2025)
Historic Profit After Tax for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to -$977000.0.
- BioLineRx's Profit After Tax rose 8321.88% to -$977000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $151000.0, marking a year-over-year increase of 10059.14%. This contributed to the annual value of -$19.3 million for FY2024, which is 5942.77% up from last year.
- Per BioLineRx's latest filing, its Profit After Tax stood at -$977000.0 for Q3 2025, which was up 8321.88% from $3.9 million recorded in Q2 2025.
- In the past 5 years, BioLineRx's Profit After Tax ranged from a high of $18.5 million in Q2 2023 and a low of -$19.5 million during Q4 2023
- In the last 3 years, BioLineRx's Profit After Tax had a median value of -$977000.0 in 2025 and averaged -$3.2 million.
- In the last 5 years, BioLineRx's Profit After Tax crashed by 9739.01% in 2024 and then skyrocketed by 83663.79% in 2025.
- Quarter analysis of 3 years shows BioLineRx's Profit After Tax stood at -$19.5 million in 2023, then skyrocketed by 59.28% to -$7.9 million in 2024, then surged by 87.69% to -$977000.0 in 2025.
- Its Profit After Tax was -$977000.0 in Q3 2025, compared to $3.9 million in Q2 2025 and $5.1 million in Q1 2025.